S&P 500

5.460,48

-0,41%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
European Biotech Acquisition Corporation (EBACU)
European Biotech Acquisition Corporation (EBACU) Notícias

EBACU

European Biotech Acquisi... (EBACU)

European Biotech Acquisition Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:EBACU

1

Data	Hora	Fonte	Título	Código	Companhia
13/03/2023	17:10	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:EBACU	European Biotech Acquisition Corporation
28/02/2023	18:13	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:EBACU	European Biotech Acquisition Corporation
28/02/2023	08:12	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:EBACU	European Biotech Acquisition Corporation
14/02/2023	18:14	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:EBACU	European Biotech Acquisition Corporation
14/02/2023	13:33	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:EBACU	European Biotech Acquisition Corporation
06/02/2023	18:44	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:EBACU	European Biotech Acquisition Corporation
03/02/2023	19:11	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (definitive) (defm14a)	NASDAQ:EBACU	European Biotech Acquisition Corporation
14/12/2022	11:17	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:EBACU	European Biotech Acquisition Corporation
14/11/2022	14:43	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:EBACU	European Biotech Acquisition Corporation
15/11/2021	19:02	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:EBACU	European Biotech Acquisition Corporation
04/06/2021	17:40	Business Wire	European Biotech Acquisition Corp. Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report	NASDAQ:EBACU	European Biotech Acquisition Corporation
14/05/2021	12:00	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:EBACU	European Biotech Acquisition Corporation
04/05/2021	18:19	Business Wire	European Biotech Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares & Warrants Commencing May 6,...	NASDAQ:EBACU	European Biotech Acquisition Corporation